May 31, 2026
1 min read

STAT+: A standing ovation for RevMed, and caution for Akeso

You’re reading the web edition of ASCO in 30 Seconds, STAT’s guide to the American Society of Clinical Oncology annual meeting. Sign up for email editions here.  

Oncologists are capable of some raucous applause, but they don’t bestow it upon just anyone. Today saw one of those coveted standing ovations, and the hoots and cheers were not held for the end.

The plenary may have passed, but ASCO isn’t over yet— we’ll be back tomorrow with our final newsletter installment, and you can catch our virtual recap on Wednesday.

Continue to STAT+ to read the full story…

Leave a Reply

Your email address will not be published.

Previous Story

STAT+: For prostate cancer patients set on surgery, new hormone regimen may improve outcomes, study finds

Next Story

The best foods high in potassium — and why you need them

Previous Story

STAT+: For prostate cancer patients set on surgery, new hormone regimen may improve outcomes, study finds

Next Story

The best foods high in potassium — and why you need them

Latest from Blog

Go toTop